市场调查报告书
商品编码
1451764
2024-2032 年按产品类型(疫苗、药品、饲料添加剂)、最终用户(乳牛场、兽医院等)和地区分類的牛隻保健市场Cattle Healthcare Market by Product Type (Vaccines, Pharmaceuticals, Feed additives), End User (Dairy farms, Veterinary hospitals, and Others), and Region 2024-2032 |
2023年,全球牛隻保健市场规模达到88亿美元。展望未来, IMARC Group预计到2032年市场规模将达到122亿美元,2024-2032年复合年增长率(CAGR)为3.62%。对动物性蛋白质需求的增加、可支配收入水准的扩大以及人畜共患疾病盛行率的增加是推动市场发展的一些关键因素。
牛保健是指对牛身心健康各方面的管理。它涉及预防、诊断和治疗健康问题,以维持动物的福祉和生产力。牛隻保健的主要目标包括防止疾病传播、确保最佳营养和生长、提供安全清洁的环境以及实施有效的疾病控制措施。定期监测和评估牛群的健康状况对于及早发现和治疗潜在的健康问题至关重要。有效的牛保健需要结合良好的管理实践、兽医护理和适当的药物使用。这可能包括疫苗接种计划、寄生虫控制、营养管理和疾病监测计划。此外,实施适当的牛隻保健措施可以改善动物福利、提高生产力并促进畜牧业的永续发展。
推动市场的主要因素之一是由于全球人口不断增长而导致对动物蛋白质的需求增加。此外,由于群众可支配收入水准不断提高,包括牛在内的牲畜产量增加,从而创造了积极的市场前景。除此之外,牛结核病、布鲁氏菌病和沙门氏菌病等人畜共通传染病的日益流行,使人们更加重视动物健康和疾病控制措施。除此之外,畜牧生产者对动物健康和福利的重要性的认识不断提高,以确保其经营的可持续性,这对市场成长产生了积极影响。与此一致的是,乳製品产业的指数级成长,特别是在新兴经济体,正在推动市场成长。除了这些因素之外,畜牧生产投资的增加导致对牛保健产品和服务的需求增加,以支持该行业。此外,日益增长的环境问题导致人们越来越关注促进永续畜牧生产的牛隻保健产品和服务。此外,世界各国政府正在采取措施促进动物健康和福利,例如疾病监测计画、疫苗接种运动和法规,以确保兽药的安全和道德使用。此外,重大技术进步正在导致疫苗、检测和药物等新型创新牛隻保健产品和服务的开发,从而创造了积极的市场前景。
The global cattle healthcare market size reached US$ 8.8 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 12.2 Billion by 2032, exhibiting a growth rate (CAGR) of 3.62% during 2024-2032. The augmenting demand for animal protein, expanding disposable income levels, and increasing prevalence of zoonotic diseases represent some of the key factors driving the market.
Cattle healthcare refers to the management of all aspects of the physical and mental health of cattle. It involves preventing, diagnosing, and treating health issues in order to maintain the well-being and productivity of the animals. The primary objectives of cattle healthcare include preventing the spread of diseases, ensuring optimal nutrition and growth, providing a safe and clean environment, and implementing effective disease control measures. Regular monitoring and evaluation of the herd's health are essential for the early detection and treatment of potential health issues. Effective cattle healthcare requires a combination of good management practices, veterinary care, and appropriate use of medications. This may include vaccination programs, parasite control, nutritional management, and disease surveillance programs. Moreover, implementing proper cattle healthcare practices can improve animal welfare, enhance productivity, and promote sustainability in the livestock industry.
One of the primary factors driving the market is the augmenting demand for animal protein due to the growing population globally. Additionally, on account of the expanding disposable income levels of the masses, there is a rise in the production of livestock, including cattle, thus creating a positive market outlook. Other than this, the increasing prevalence of zoonotic diseases, such as bovine tuberculosis, brucellosis, and salmonellosis, is creating a greater emphasis on animal health and disease control measures. Besides this, the rising awareness among livestock producers regarding the importance of animal health and welfare to ensure the sustainability of their operations is positively influencing market growth. In line with this, the exponential growth in the dairy industry, specifically in emerging economies, is propelling the market growth. Apart from these factors, the increasing investment in livestock production is leading to increased demand for cattle healthcare products and services to support the industry. Furthermore, the growing environmental concerns have led to an increasing focus on cattle healthcare products and services that promote sustainable livestock production. Moreover, governments across the world are taking initiatives to promote animal health and welfare, such as disease surveillance programs, vaccination campaigns, and regulations, to ensure the safe and ethical use of veterinary drugs. Furthermore, significant technological advancements are leading to the development of new and innovative cattle healthcare products and services, such as vaccines, tests, and medicines, thus creating a positive market outlook.
IMARC Group provides an analysis of the key trends in each segment of the global cattle healthcare market, along with forecasts at the global, regional, and country levels from 2024-2032. Our report has categorized the market based on the product type and end user.
Vaccines
Pharmaceuticals
Analgesics
Anti-infective
Anti-inflammatory
Parasiticides
Others
Feed additives
Medicinal
Nutritional
The report has provided a detailed breakup and analysis of the cattle healthcare market based on the product type. This includes vaccines, pharmaceuticals (analgesics, anti-infectives, anti-inflammatory, parasiticides, and others), and feed additives (medicinal and nutritional).
Dairy farms
Veterinary hospitals
Others
A detailed breakup and analysis of the cattle healthcare market based on the end user has also been provided in the report. This includes dairy farms, veterinary hospitals, and others. According to the report, veterinary hospitals accounted for the largest market share.
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for cattle healthcare. Some of the factors driving the North America cattle healthcare market included increasing demand for animal protein, technological advancements in veterinary medicine, and rising awareness of animal welfare.
The report has also provided a comprehensive analysis of the competitive landscape in the global cattle healthcare market. Detailed profiles of all major companies have also been provided. Some of the companies covered include BioZyme Inc., Boehringer Ingelheim International GmbH (C.H. Boehringer Sohn AG & Co. KG), Ceva Sante Animate, Elanco Animal Health Incorporated, Merck & Co. Inc., Virbac, Zoetis Inc., etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.